Datametrex AI Ltd V.DM

Alternate Symbol(s): DTMXF

Technology Information Technology Services

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.

TSXV:DM - Post by User

Datametrex AI Ltd

<< Previous

Bullboard Posts

Next >>

Post by massimilianoon Nov 27, 2020 10:24am

860 Views

Post# 31988502

Q3 2020 Report: Datametrex Scores $7.6M Revenue

Q3 2020 Report: Datametrex Scores $7.6M Revenue
Datametrex AI Ltd. (TSX-V: DM, OTC: DTMXF, Forum) released its Q3 2020 financial results this week, highlighting revenue of $7.6 million (CAD),a 189% increase compared to the same period last year. The Company stated that it generated a net profit, excluding several expenses.

The Adjusted EBITDA showed an improvement achieving a positive Adjusted EBITDA of $362,059, compared to $539,116 in the same period of last year. With a balance sheet of $1.4 million cash and $2 million receivables, DM’s Chief Executive Officer, Marshall Gunter stated that multiple key milestones were also achieved, including a significant increase in gross revenue and improvement in its cash position.

“This positive outcome was a direct result of our quick response in implementing a plan to begin selling test kits as result of the global impact of the COVID-19 virus. This resulted in a substantial improvement to the bottom line.”

https://stockhouse.com/news/newswire/2020/11/27/q3-2020-report-datametrex-scores-7-6m-revenue

Q3 2020 Report: Datametrex Scores $7.6M Revenue

<< Previous

Bullboard Posts

Next >>

FDA committee rejects MDMA drug, discounting psychedelic stocks